NCCN Policy Summit: Reducing the Cancer Burden Through Prevention and Early Detection [0.03%]
NCCN政策峰会：通过预防和早期检测减少癌症负担
Lindsey Bandini,Alyssa Schatz,Victoria Hood et al.
Lindsey Bandini et al.
Cancer prevention, screening, and early detection play an integral role in cancer incidence and outcomes. It is estimated that 30% to 50% of cancers worldwide are preventable, and it is well established that early detection of many cancers ...
Jessica A Steadman,Travis E Grotz
Jessica A Steadman
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30% of malignant mesothelioma cases. The primary curative therapy for MPeM is radical cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemothera...
Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy [0.03%]
预防性生长因子使用对高危化疗后发烧性中性粒细胞减少症和感染的时间影响的现实世界研究
Douglas W Blayney,Nicole M Kuderer,Alice Kate Cummings Joyner et al.
Douglas W Blayney et al.
Background: Prophylactic growth-factor therapy with granulocyte colony-stimulating factor (G-CSF) reduces the risk of febrile neutropenia (FN) in patients with breast cancer initiating myelosuppressive chemotherapy. Howev...
Hidden Disparities: How Language Influences Patients' Access to Cancer Care [0.03%]
语言差异：语言如何影响癌症患者的就医体验
Debbie W Chen,Mousumi Banerjee,Xin He et al.
Debbie W Chen et al.
Background: Patients with limited English proficiency, a vulnerable patient population, remain understudied in the literature addressing cancer disparities. Although it is well documented that language discordance between...
Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study [0.03%]
撒哈拉以南非洲结直肠癌患者的治疗和生存状况：一项基于人口的多中心随访研究
Lucia Hämmerl,Nikolaus C S Mezger,Tobias P Seraphin et al.
Lucia Hämmerl et al.
Background: The burden of colorectal cancer (CRC) is increasing in Sub-Saharan Africa (SSA). However, little is known about CRC treatment and survival in the region. ...
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology [0.03%]
2023年NCCN肿瘤学临床实践指南：恶性胶质瘤版本2.2023
David S Ettinger,Douglas E Wood,James Stevenson et al.
David S Ettinger et al.
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines ...
Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112 [0.03%]
肌肉测量对内分泌治疗转移性乳腺癌患者预后的影响：ECOG-ACRIN E2112试验分析
Tarah J Ballinger,Helga S Marques,Gloria Xue et al.
Tarah J Ballinger et al.
Background: Observational data investigating the relationship between body habitus and outcomes in breast cancer have been variable and inconsistent, largely centered in the curative setting and focused on weight-based me...
BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case Series [0.03%]
BRAF/MEK抑制剂作为桥接免疫治疗有症状的BRAF V600黑色素瘤脑转移病灶的一组病例报告
Jacob Strelnikov,Alice Zhou,Omar Butt et al.
Jacob Strelnikov et al.
Targeted and immune therapies have changed the paradigm of treatment for patients with metastatic melanoma. Treatment of patients with symptomatic melanoma brain metastases, however, is complicated by the frequent use of immune suppression ...
Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma [0.03%]
分子分型可改善婴幼儿髓母细胞瘤的治疗选择
Aditi Bagchi,Sandeep K Dhanda,Paige Dunphy et al.
Aditi Bagchi et al.
Medulloblastoma in infants and young children is a major challenge to treat because craniospinal irradiation (CSI), a cornerstone of therapy for older children, is disproportionately damaging to very young children. As a result, trials have...
Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3 [0.03%]
激素受体阳性乳腺癌对派姆单抗敏感：MLH1变异1835del3致病性的证据
Henry G Kaplan,Jeffrey R Whiteaker,Brianna Nelson et al.
Henry G Kaplan et al.
A woman with estrogen/progesterone receptor-positive, ERBB2-negative metastatic breast cancer developed progressive disease despite treatment with multiple hormonal and chemotherapeutic modalities. She carried a germline variant of MLH1 (18...